Furthermore, our data provide a molecular basis to explain GPRC5A overexpression previously observed in solid tumours, such as pancreatic cancers (Zhou & Rigoutsos, 2014; Zhou et al, 2016). This evidence concerns the gene GPRC5A and pancreatic neoplasm.